Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director | May 13, 2026 | May 14, 2026 |
| IPG PHOTONICS CORPIPGP · Entity 1767 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,539 |
Reported balance
After 2026-05-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-13 · Exercise / conversion · Acquired 1,254 · Balance 4,539 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-05-13 | Direct | 0 |
Reported balance
After 2026-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-13 · Exercise / conversion · Disposed 1,254 · Balance 0 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13 | Direct | 1,475 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Grant · Acquired 1,475 · Balance 1,475 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are Restricted Stock Units.
F2: There is neither a purchase price nor an exercise price for Restricted Stock Units.
F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.
IPG PHOTONICS CORP
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,513 |
Reported balance
After 2026-05-12 transaction · row 1
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 2,436 · Balance 11,513 F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 29,249 · Balance 0 F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting. F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.68 · Expires 2025-02-08 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 1,630 · Balance 0 F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.73 · Expires 2026-02-14 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 6,002 · Balance 0 F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.59 · Expires 2027-02-13 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 14,122 · Balance 0 F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-15 · Disposition to issuer · Disposed 1,063 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-15 · Disposition to issuer · Disposed 12,103 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-15 · Disposition to issuer · Disposed 1,906 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-04-15 · Disposition to issuer · Disposed 8,859 · Balance 0 F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-04-15 · Disposition to issuer · Disposed 10,777 · Balance 0 F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock.
F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.
F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock.
F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2019 Filed Feb 20, 2019 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007307 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · Pres. Proton Solutions, CGO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,683 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-007307 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · Pres. Proton Solutions, CGO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 19:31 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 3,187 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006979 · form4.xml · derivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,622 Underlying: Common Stock · 3,187 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 14, 2020, February 14, 2021, and February 14, 2022. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 14, 2020, February 14, 2021, and February 14, 2022. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 19:31 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 14,403 | $0.00 Strike: $131.77 | $0.00 |
DisclosureSEC source: 0001127602-19-006979 · form4.xml · derivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,403 Underlying: Common Stock · 14,403 shares Expires 2026-02-14 F1 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 14, 2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 669 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-006129 · form4.xml · derivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 669 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 419 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-006129 · form4.xml · derivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669 Underlying: Common Stock · 419 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 669 | $132.85 | $88,875.91 |
DisclosureSEC source: 0001127602-19-006129 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 669 shares were sold in multiple transactions executed on the same day at prices ranging from $132.62 to $132.97. The detailed breakdown of executed sales will be furnished upon request Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 669 | $67.12 | $44,903.28 |
DisclosureSEC source: 0001127602-19-006129 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 419 | $132.12 | $55,357.02 |
DisclosureSEC source: 0001127602-19-006129 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 419 shares were sold in multiple transactions executed on the same day at prices ranging from $131.61 to $132.58. The detailed breakdown of executed sales will be furnished upon request Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:12 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 419 | $67.12 | $28,123.28 |
DisclosureSEC source: 0001127602-19-006129 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 699 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-005785 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,391 Underlying: Common Stock · 699 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 699 | $131.45 | $91,885.79 |
DisclosureSEC source: 0001127602-19-005785 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 699 shares were sold in multiple transactions executed on the same day at prices ranging from $131.22 to $131.99. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 19:58 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 699 | $80.40 | $56,199.60 |
DisclosureSEC source: 0001127602-19-005785 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 16:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 429 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-19-005383 · form4.xml · derivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,036 Underlying: Common Stock · 429 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 16:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 6,088 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001127602-19-005383 · form4.xml · derivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,465 Underlying: Common Stock · 6,088 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 16:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 429 | $130.59 | $56,023.84 |
DisclosureSEC source: 0001127602-19-005383 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 429 shares were sold in multiple transactions executed on the same day at prices ranging from $130.57 to $130.65. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 16:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 429 | $112.82 | $48,399.78 |
DisclosureSEC source: 0001127602-19-005383 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 16:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 6,088 | $130.06 | $791,825.37 |
DisclosureSEC source: 0001127602-19-005383 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 6,088 shares were sold in multiple transactions executed on the same day at prices ranging from $129.54 to $130.53. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 16:41 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 6,088 | $112.82 | $686,848.16 |
DisclosureSEC source: 0001127602-19-005383 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 932 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · derivative · entry 12 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 932 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F9 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 5,593 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · derivative · entry 11 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,090 Underlying: Common Stock · 5,593 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F8 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 5,155 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · derivative · entry 10 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,088 Underlying: Common Stock · 5,155 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F7 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · derivative · entry 9 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,243 Underlying: Common Stock · 7,900 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F7 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 932 | $131.34 | $122,408.97 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 8 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F6 · price: The 932 shares were sold in multiple transactions executed on the same day at prices ranging from $131.28 to $131.41. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 932 | $81.97 | $76,396.04 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 7 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 5,593 | $131.09 | $733,173.51 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 5,593 shares were sold in multiple transactions executed on the same day at prices ranging from $130.895 to $131.28. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 5,593 | $80.40 | $449,677.20 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 5,155 | $130.56 | $673,048.14 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 5,155 shares were sold in multiple transactions executed on the same day at prices ranging from $130.38 to $130.8950. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 5,155 | $67.12 | $346,003.60 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 7,900 | $129.89 | $1,026,111.25 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 7,900 shares were sold in multiple transactions executed on the same day at prices ranging from $129.37 to $130.36. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 20:00 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 7,900 | $67.12 | $530,248.00 |
DisclosureSEC source: 0001127602-19-003130 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:51 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 6,462 | $125.00 | $807,750.00 |
DisclosureSEC source: 0001127602-19-002033 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,898 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 14:39 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 2,674 | $118.76 | $317,564.24 |
DisclosureSEC source: 0001127602-18-033904 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,360 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. F4 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 42 shares purchased on October 26, 2018 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 14:39 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 6,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-033904 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,034 F3 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted on November 30, 2015. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 14:39 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 2,836 | $118.76 | $336,803.36 |
DisclosureSEC source: 0001127602-18-033904 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,783 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 14:39 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 5,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-033904 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,619 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted on February 12, 2016. Read SEC document |
| May 10, 2018 Filed May 11, 2018 17:23 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 699 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-18-017216 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,683 Underlying: Common Stock · 699 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| May 10, 2018 Filed May 11, 2018 17:23 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 699 | $118.20 | $82,623.69 |
DisclosureSEC source: 0001127602-18-017216 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,856 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 699 shares were sold in multiple transactions executed on the same day at prices ranging from $117.62 to $118.59. The detailed breakdown of executed sales will be furnished upon request. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 194 shares purchased on April 27, 2018 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 10, 2018 Filed May 11, 2018 17:23 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 699 | $80.40 | $56,199.60 |
DisclosureSEC source: 0001127602-18-017216 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| April 10, 2018 Filed Apr 10, 2018 18:54 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 699 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-18-014345 · form4.xml · derivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,382 Underlying: Common Stock · 699 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| April 10, 2018 Filed Apr 10, 2018 18:54 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 200 | $120.88 | $24,175.00 |
DisclosureSEC source: 0001127602-18-014345 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 200 shares were sold in multiple transactions executed on the same day at prices ranging from $120.75 to $121.00. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| April 10, 2018 Filed Apr 10, 2018 18:54 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 499 | $120.12 | $59,938.03 |
DisclosureSEC source: 0001127602-18-014345 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,862 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 499 shares were sold in multiple transactions executed on the same day at prices ranging from $119.67 to $120.54. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| April 10, 2018 Filed Apr 10, 2018 18:54 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 699 | $80.40 | $56,199.60 |
DisclosureSEC source: 0001127602-18-014345 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| March 12, 2018 Filed Mar 12, 2018 19:56 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 699 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-18-011281 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,081 Underlying: Common Stock · 699 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| March 12, 2018 Filed Mar 12, 2018 19:56 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 699 | $126.47 | $88,400.57 |
DisclosureSEC source: 0001127602-18-011281 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 699 shares were sold in multiple transactions executed on the same day at prices ranging from $126.02 to $126.69. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| March 12, 2018 Filed Mar 12, 2018 19:56 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 699 | $80.40 | $56,199.60 |
DisclosureSEC source: 0001127602-18-011281 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| February 16, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 3,513 | $121.16 | $425,621.73 |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · nonDerivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,662 F3 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 3,513 shares were sold in multiple transactions executed on the same day at prices ranging from $120.965 to $121.365. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,683 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · derivative · entry 8 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,435 Underlying: Common Stock · 1,683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F8 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. F8 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · derivative · entry 7 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,118 Underlying: Common Stock · 1,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F7 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. F7 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 19:10 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 2,237 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-006843 · form4.xml · derivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,462 Underlying: Common Stock · 2,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F6 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date. F6 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.